These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 11114718)

  • 1. Induction of p21WAF1/CIP1 and cyclin D1 expression by the Src oncoprotein in mouse fibroblasts: role of activated STAT3 signaling.
    Sinibaldi D; Wharton W; Turkson J; Bowman T; Pledger WJ; Jove R
    Oncogene; 2000 Nov; 19(48):5419-27. PubMed ID: 11114718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Constitutive activation of Stat3 in fibroblasts transformed by diverse oncoproteins and in breast carcinoma cells.
    Garcia R; Yu CL; Hudnall A; Catlett R; Nelson KL; Smithgall T; Fujita DJ; Ethier SP; Jove R
    Cell Growth Differ; 1997 Dec; 8(12):1267-76. PubMed ID: 9419415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclin D1 is transcriptionally regulated by and required for transformation by activated signal transducer and activator of transcription 3.
    Leslie K; Lang C; Devgan G; Azare J; Berishaj M; Gerald W; Kim YB; Paz K; Darnell JE; Albanese C; Sakamaki T; Pestell R; Bromberg J
    Cancer Res; 2006 Mar; 66(5):2544-52. PubMed ID: 16510571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-hydroxytryptamine 2B receptor regulates cell-cycle progression: cross-talk with tyrosine kinase pathways.
    Nebigil CG; Launay JM; Hickel P; Tournois C; Maroteaux L
    Proc Natl Acad Sci U S A; 2000 Mar; 97(6):2591-6. PubMed ID: 10688905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. v-Abl utilizes multiple mechanisms to drive G1/S progression in fibroblasts.
    Coutts M; Zou X; Calame K
    Oncogene; 2000 Feb; 19(6):801-9. PubMed ID: 10698498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of the v-Src oncoprotein in fibroblasts disrupts normal regulation of the CDK inhibitor p27 and inhibits quiescence.
    Johnson D; Frame MC; Wyke JA
    Oncogene; 1998 Apr; 16(15):2017-28. PubMed ID: 9591786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth inhibition of human hepatoma cells by acyclic retinoid is associated with induction of p21(CIP1) and inhibition of expression of cyclin D1.
    Suzui M; Masuda M; Lim JT; Albanese C; Pestell RG; Weinstein IB
    Cancer Res; 2002 Jul; 62(14):3997-4006. PubMed ID: 12124333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence that leptin through STAT and CREB signaling enhances cyclin D1 expression and promotes human endometrial cancer proliferation.
    Catalano S; Giordano C; Rizza P; Gu G; Barone I; Bonofiglio D; Giordano F; Malivindi R; Gaccione D; Lanzino M; De Amicis F; Andò S
    J Cell Physiol; 2009 Mar; 218(3):490-500. PubMed ID: 18988190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of oncogene-mediated transformation by ectopic expression of p21Waf1 in NIH3T3 cells.
    Michieli P; Li W; Lorenzi MV; Miki T; Zakut R; Givol D; Pierce JH
    Oncogene; 1996 Feb; 12(4):775-84. PubMed ID: 8632899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transformation fingerprint: induced STAT3-C, v-Src and Ha-Ras cause small initial changes but similar established profiles in mRNA.
    Paz K; Socci ND; van Nimwegen E; Viale A; Darnell JE
    Oncogene; 2004 Nov; 23(52):8455-63. PubMed ID: 15378015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
    Ioachim E
    Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. v-Jun stimulates both cdk2 kinase activity and G1/S progression via transcriptional repression of p21 CIP1.
    Maclaren A; Clark W; Black EJ; Gregory D; Fujii H; Gillespie DA
    Oncogene; 2003 Apr; 22(16):2383-95. PubMed ID: 12717415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of insulin receptor substrate-1 in transformation by v-src.
    Sun H; Baserga R
    J Cell Physiol; 2008 Jun; 215(3):725-32. PubMed ID: 18064649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis.
    Niu G; Wright KL; Huang M; Song L; Haura E; Turkson J; Zhang S; Wang T; Sinibaldi D; Coppola D; Heller R; Ellis LM; Karras J; Bromberg J; Pardoll D; Jove R; Yu H
    Oncogene; 2002 Mar; 21(13):2000-8. PubMed ID: 11960372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidermal growth factor increases the level of the cyclin-dependent kinase (CDK) inhibitor p21/CIP1 (CDK-interacting protein 1) in A431 cells by increasing the half-lives of the p21/CIP1 transcript and the p21/CIP1 protein.
    Johannessen LE; Knardal SL; Madshus IH
    Biochem J; 1999 Feb; 337 ( Pt 3)(Pt 3):599-606. PubMed ID: 9895307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RhoE inhibits cell cycle progression and Ras-induced transformation.
    Villalonga P; Guasch RM; Riento K; Ridley AJ
    Mol Cell Biol; 2004 Sep; 24(18):7829-40. PubMed ID: 15340047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Constitutive activation of signal transducers and activators of transcription 3 correlates with cyclin D1 overexpression and may provide a novel prognostic marker in head and neck squamous cell carcinoma.
    Masuda M; Suzui M; Yasumatu R; Nakashima T; Kuratomi Y; Azuma K; Tomita K; Komiyama S; Weinstein IB
    Cancer Res; 2002 Jun; 62(12):3351-5. PubMed ID: 12067972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell cycle- and protein kinase C-specific effects of resiniferatoxin and resiniferonol 9,13,14-ortho-phenylacetate in intestinal epithelial cells.
    Frey MR; Clark JA; Bateman NW; Kazanietz MG; Black AR; Black JD
    Biochem Pharmacol; 2004 May; 67(10):1873-86. PubMed ID: 15130764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Notch1 signaling inhibits growth of human hepatocellular carcinoma through induction of cell cycle arrest and apoptosis.
    Qi R; An H; Yu Y; Zhang M; Liu S; Xu H; Guo Z; Cheng T; Cao X
    Cancer Res; 2003 Dec; 63(23):8323-9. PubMed ID: 14678992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclin D1, p53, and p21Waf1/Cip1 expression is predictive of poor clinical outcome in serous epithelial ovarian cancer.
    Bali A; O'Brien PM; Edwards LS; Sutherland RL; Hacker NF; Henshall SM
    Clin Cancer Res; 2004 Aug; 10(15):5168-77. PubMed ID: 15297421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.